Christopher P Tinworth

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Venues

Nature communications

ACS chemical biology

Chemistry (Weinheim an der Bergstrasse, Germany)

Journal of medicinal chemistry

GlaxoSmithKline/University of Strathclyde (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

GlaxoSmithKline/University of Strathclyde Sep 23 2013 - Jun 07 2017

United Kingdom

PHD :: Synthetic and Medicinal Chemistry

Publications

John D Harling, Christopher P Tinworth
A two-faced selectivity solution to target SMARCA2 for cancer therapy. Nature communications 14 (1) (2023)
John D Harling, Christopher P Tinworth
A two-faced selectivity solution to target SMARCA2 for cancer therapy. Nature communications 14 (1) (2023)
John D Harling, Christopher P Tinworth
A two-faced selectivity solution to target SMARCA2 for cancer therapy. Nature communications 14 (1) (2023)
John D Harling, Christopher P Tinworth
A two-faced selectivity solution to target SMARCA2 for cancer therapy. Nature communications 14 (1) (2023)
Qisi Zhang, Cyrille S Kounde, Milon Mondal, Jake L Greenfield, Jennifer R Baker, Sergei Kotelnikov, Mikhail Ignatov, Christopher P Tinworth, Leran Zhang, Daniel Conole, Elena De Vita, Dima Kozakov, Adam McCluskey, John D Harling, Matthew John Fuchter, Edward William Tate
Light-mediated multi-target protein degradation using arylazopyrazole photoswitchable PROTACs (AP-PROTACs). Chemical communications (Cambridge, England) 58 (78) (2022)
Adam I Green, Christopher P Tinworth, Stuart Warriner, Adam Nelson, Natalie Fey
Computational Mapping of Dirhodium(II) Catalysts. Chemistry (Weinheim an der Bergstrasse, Germany) 27 (7) (2021)
Adam I Green, Fruzsina Hobor, Christopher P Tinworth, Stuart L Warriner, Andrew J Wilson, Adam Nelson
Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (47) (2020)
John Liddle, Jonathan P Hutchinson, Semra Kitchen, Paul Rowland, Margarete Neu, Ted Cecconie, Duncan S Holmes, Emma Jones, Justyna Korczynska, Despoina Koumantou, Jonathan D Lea, Leng Nickels, Michelle Pemberton, Alex Phillipou, Jessica L Schneck, Hester Sheehan, Christopher P Tinworth, Iain Uings, Justyna Wojno-Picon, Robert J Young, Efstratios Stratikos
Targeting the Regulatory Site of ER Aminopeptidase 1 Leads to the Discovery of a Natural Product Modulator of Antigen Presentation. Journal of medicinal chemistry 63 (6) (2020)
Chun-Wa Chung, Han Dai, Esther Fernandez, Christopher P Tinworth, Ian Churcher, Jenni Cryan, Jane Denyer, John D Harling, Agnieszka Konopacka, Markus A Queisser, Christopher J Tame, Gillian Watt, Fan Jiang, Dongming Qian, Andrew B Benowitz
Structural Insights into PROTAC-Mediated Degradation of Bcl-xL. ACS chemical biology 15 (9) (2020)
Christopher P Tinworth, Robert J Young
Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data. Journal of medicinal chemistry 63 (18) (2020)
Christopher P Tinworth, Hannah Lithgow, Lars Dittus, Zuni I Bassi, Sophie E Hughes, Marcel Muelbaier, Han Dai, Ian E D Smith, William J Kerr, Glenn A Burley, Marcus Bantscheff, John D Harling
PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding. ACS chemical biology 14 (3) (2019)

Christopher P Tinworth.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher P Tinworth